Posttranslational Modifications Affect the Interaction of S100 Proteins with Tumor Suppressor p53

Journal of Molecular Biology

Volumn 394, Issue 5, 2009, Pages 922-930

  van Dieck, Jan ^a   Teufel, Daniel P ^a   Jaulent, Agnes M ^a   Fernandez Fernandez, Maria R ^a   Rutherford, Trevor J ^a   Wyslouch Cieszynska, Alexandra ^b   Fersht, Alan R ^a  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

p53; posttranslational modification; protein protein interaction; S100

Indexed keywords

CALCYCLIN; CALVASCULIN; PROTEIN P53; PROTEIN S 100; PROTEIN S100A1; PROTEIN S100A2; PROTEIN S100B; SERINE; THREONINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

EID: 70449685710     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.10.002     Document Type: Article

References (48)

1. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
2. Vousden K.H. p53: death star. Cell 103 (2000) 691-694
3. Toledo F., and Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer 6 (2006) 909-923
4. Lavin M.F., and Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 13 (2006) 941-950
5. May P., and May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18 (1999) 7621-7636
6. Walker K.K., and Levine A.J. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl Acad. Sci. USA 93 (1996) 15335-15340
7. Zhu J., Zhou W., Jiang J., and Chen X. Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J. Biol. Chem. 273 (1998) 13030-13036
8. Candau R., Scolnick D.M., Darpino P., Ying C.Y., Halazonetis T.D., and Berger S.L. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15 (1997) 807-816
9. Tang Y., Zhao W., Chen Y., Zhao Y., and Gu W. Acetylation is indispensable for p53 activation. Cell 133 (2008) 612-626
10. Baudier J., Delphin C., Grunwald D., Khochbin S., and Lawrence J.J. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl Acad. Sci. USA 89 (1992) 11627-11631
11. Fernandez-Fernandez M.R., Rutherford T.J., and Fersht A.R. Members of the S100 family bind p53 in two distinct ways. Protein Sci. 17 (2008) 1663-1670
12. Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc. Natl Acad. Sci. USA 102 (2005) 4735-4740
13. Grigorian M., Andresen S., Tulchinsky E., Kriajevska M., Carlberg C., Kruse C., et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276 (2001) 22699-22708
14. Lin J., Blake M., Tang C., Zimmer D., Rustandi R.R., Weber D.J., and Carrier F. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem. 276 (2001) 35037-35041
15. Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., et al. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem. 280 (2005) 29186-29193
16. Scotto C., Deloulme J.C., Rousseau D., Chambaz E., and Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18 (1998) 4272-4281
17. Scotto C., Delphin C., Deloulme J.C., and Baudier J. Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C. Mol. Cell. Biol. 19 (1999) 7168-7180
18. Slomnicki L.P., Nawrot B., and Lesniak W. S100A6 binds p53 and affects its activity. Int. J. Biochem. Cell Biol. 41 (2008) 784-790
19. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
20. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33 (2001) 637-668
21. Heizmann C.W., Fritz G., and Schafer B.W. S100 proteins: structure, functions and pathology. Front. Biosci. 7 (2002) d1356-d1368
22. Davies M.P., Rudland P.S., Robertson L., Parry E.W., Jolicoeur P., and Barraclough R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13 (1996) 1631-1637
23. Salama I., Malone P.S., Mihaimeed F., and Jones J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34 (2008) 357-364
24. van Dieck J., Fernandez-Fernandez M.R., Veprintsev D.B., and Fersht A.R. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J. Biol. Chem. 284 (2009) 13804-13811
25. Lomax M.E., Barnes D.M., Hupp T.R., Picksley S.M., and Camplejohn R.S. Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members. Oncogene 17 (1998) 643-649
26. Lin J., Chen J., Elenbaas B., and Levine A.J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8 (1994) 1235-1246
27. Teufel D.P., Freund S.M., Bycroft M., and Fersht A.R. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc. Natl Acad. Sci. USA 104 (2007) 7009-7014
28. Bode A.M., and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4 (2004) 793-805
29. Zhukova L., Zhukov I., Bal W., and Wyslouch-Cieszynska A. Redox modifications of the C-terminal cysteine residue cause structural changes in S100A1 and S100B proteins. Biochim. Biophys. Acta 1742 (2004) 191-201
30. Rustandi R.R., Baldisseri D.M., and Weber D.J. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat. Struct. Biol. 7 (2000) 570-574
31. Teufel D.P., Bycroft M., and Fersht A.R. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene 28 (2009) 2122-2128
32. Saito S., Goodarzi A.A., Higashimoto Y., Noda Y., Lees-Miller S.P., Appella E., and Anderson C.W. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277 (2002) 12491-12494
33. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13 (1999) 152-157
34. Shieh S.Y., Ikeda M., Taya Y., and Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 (1997) 325-334
35. She Q.B., Chen N., and Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275 (2000) 20444-20449
36. Gatti A., Li H.H., Traugh J.A., and Liu X. Phosphorylation of human p53 on Thr-55. Biochemistry 39 (2000) 9837-9842
37. Li H.H., Li A.G., Sheppard H.M., and Liu X. Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol. Cell 13 (2004) 867-878
38. Chehab N.H., Malikzay A., Stavridi E.S., and Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl Acad. Sci. USA 96 (1999) 13777-13782
39. Unger T., Juven-Gershon T., Moallem E., Berger M., Vogt Sionov R., Lozano G., et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18 (1999) 1805-1814
40. Wilder P.T., Lin J., Bair C.L., Charpentier T.H., Yang D., Liriano M., et al. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim. Biophys. Acta 1763 (2006) 1284-1297
41. Chernov M.V., Bean L.J., Lerner N., and Stark G.R. Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation. J. Biol. Chem. 276 (2001) 31819-31824
42. Waterman M.J., Stavridi E.S., Waterman J.L., and Halazonetis T.D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19 (1998) 175-178
43. Burge S., Teufel D.P., Townsley F.M., Freund S.M., Bycroft M., and Fersht A.R. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation. Proc. Natl Acad. Sci. USA 106 (2009) 3142-3147
44. Lim S.Y., Raftery M., Cai H., Hsu K., Yan W.X., Hseih H.L., et al. S-nitrosylated S100A8: novel anti-inflammatory properties. J. Immunol. 181 (2008) 5627-5636
45. Leon L., Jeannin J.F., and Bettaieb A. Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis. Nitric Oxide 19 (2008) 77-83
46. Yu G.W., Rudiger S., Veprintsev D., Freund S., Fernandez-Fernandez M.R., and Fersht A.R. The central region of HDM2 provides a second binding site for p53. Proc. Natl Acad. Sci. USA 103 (2006) 1227-1232
47. Friedler A., Hansson L.O., Veprintsev D.B., Freund S.M., Rippin T.M., Nikolova P.V., et al. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants. Proc. Natl Acad. Sci. USA 99 (2002) 937-942
48. Friedler A., Veprintsev D.B., Freund S.M., von Glos K.I., and Fersht A.R. Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure 13 (2005) 629-636